ATRA Atara Biotherapeutics, Inc.: Earnings per share for the last twelve months
Atara Biotherapeutics maintains a steady production of drugs thanks to its own manufacturing facility in California. The 12-month EPS history on the GURU.Markets chart reflects the dynamics of this process, with the value holding at -1.23. However, raw material shortages driven by geopolitics are hindering drug registration, while the development of the Ebvallo platform within the R&D pipeline is currently undergoing a stage of moderate protocol optimization.
Analytical breakdowns and data insights for company Atara Biotherapeutics, Inc. (ATRA)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Atara Biotherapeutics|ATRA - Long-Term Liabilities to Capital|Short-Term Debt to Capital Atara Biotherapeutics Inc|ATRA - Company Aggregate Debts|Debt to Book Value Atara Bio|ATRA - Amount of Long-Term Liabilities|Company Short-Term Debts Atara Biotherapeutics|Quick Liquidity atarabio.com
- earnings and valuation multiples indicators:
ATRA - Final Profit|Projected Future Earnings Atara Biotherapeutics|ATRA - P/E Multiple|Projected Price to Earnings Atara Biotherapeutics Inc|ATRA - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Atara Bio|ATRA - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Atara Biotherapeutics|ATRA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months atarabio.com|ATRA - Earnings per share growth rate in current year|Expected earnings per share growth for next year Atara Biotherapeutics
- sales and revenue data:
Analysis of all company metrics:atarabio.com - ATRA
The implementation of robotic platforms and predictive software within Atara Biotherapeutics (ATRA) laboratories directly impacts operational efficiency. The 12-month EPS trend reflects the final net income allocated per share over a rolling year. This metric allows for an assessment of the business's actual unit profitability, stripped of the influence of issuance volume. The stability of the curve on this chart confirms the resilience of the model, although it may signal an overvalued asset. The dynamics of this metric determine the company's fair market capitalization.
Who Atara Biotherapeutics competes with
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|BCRX - Net earnings per share (EPS TTM)|VERA (Vera Therapeutics, Inc.) - Net earnings per share for the last 12 months|DNTH: Earnings per share for the last four quarters|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) AbCellera Biologics Inc|Earnings per share for the last twelve months Tourmaline Corp (TRML)|PGEN (Precigen Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|Net earnings per share (EPS TTM) nektar.com NKTR|UPB: Net earnings per share for the last 12 months|Earnings per share for the trailing year ZBIO (Zenas Bio)|IMNM: Net earnings per share (EPS TTM)|GOSS (Gossamer Bio Corp.) - Earnings per share for the last twelve months|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|septerna.com (SEPN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. (PVLA)|SVRA - Net earnings per one share for the last twelve months|Rigel Pharmaceuticals Inc - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANAB (AnaptysBio Inc.)|Astria Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ENGN (engene.com)|RAPT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aerovate Therapeutics (JBIO)|Earnings per share for the last twelve months Aclaris|KYTX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TLSA|Net earnings per share (EPS TTM) cabalettabio.com (CABA)|Earnings per share for the last twelve months Ventyx Biosciences, Inc. VTYX|THTX (Theratechnologies, Inc.) - Earnings per one share for the last 12 months|Avalo Therapeutics Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Eledon Pharmaceuticals, Inc|AGEN (Agenus) - Net earnings per share for the last 12 months|climbbio.com (CLYM) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ZURA|ATYR (aTyr Pharma Inc) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|Net earnings per share for the last four quarters ikenaoncology.com|Net earnings per share (EPS TTM) STTK (Shattuck Labs)|EQ - Net earnings per share for the last 12 months|CNTB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Immunic, Inc. IMUX|IFRX: Net earnings per share (EPS TTM)|X4 Pharmaceuticals, Inc (XFOR) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ACET|CELU (Celularity Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months INmune Bio (INMB)|BRNS (Barinthus Biotherapeutics PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) KZR (Kezar Life Sciences, Inc)|Net earnings per share (EPS TTM) SAB Biotherapeutics Inc SABS|AKTX - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ENLV|QTTB: Net earnings per share (EPS TTM)|GeoVax Labs - Earnings per share for the trailing year|EDSA (Edesa) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) iBio Corporation|Earnings per share for the last twelve months Carisma Therapeutics (CARM)|XTLB (xtlbio.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Bolt Biotherapeutics, Inc. BOLT|HCWB - Net earnings per share for the last 12 months|Aptevo - Net earnings per share (EPS TTM)|AIM - Net earnings per share (EPS TTM)|ADTX (aditxt.com) - Net earnings per share for the last 12 months|gribio.com - Earnings per share for the trailing year|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Vyome Holdings Inc. (HIND) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Revelation Bio (REVB)|Net earnings per share for the last 12 months Indaptus Corp INDP|Earnings per share for the last twelve months Scinai Immunotherapeutics SCNI|CALI - Net earnings per share for the last 12 months|AFMD: Net earnings per share for the last 12 months|ALLK - Net earnings per share (EPS TTM)|hookipapharma.com (HOOK) - Earnings per share for the last twelve months|Earnings per share for the last 12 months IGMS|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months oceanbiomedical.com OCEA|Net earnings per share (EPS TTM) TCBP|Net earnings per share (EPS TTM) Third Harmonic Bio Inc. (THRD)
